InvestorsHub Logo
Followers 7
Posts 240
Boards Moderated 0
Alias Born 10/02/2013

Re: hmoney post# 32859

Monday, 10/10/2016 12:45:02 PM

Monday, October 10, 2016 12:45:02 PM

Post# of 54996
You're in the ballpark.
XXII has patented technology that allows them to manipulate the amount of nicotine in tobacco that they grow. (They also have similar patented technology which allows them to manipulate the amount of THC in cannabis and hemp.) XXII therefore can reduce the amount of nicotine in cigs to levels that can help smokers who either want to quit or cut down how many cigs they smoke. Numerous independent studies have concluded that reduced nicotine content in cigs can significantly assist with smoking cessation.
In respect of the FDA submission and XXII's MRTP application - the FDA has 365 days to respond - not necessarily 365 days to approve (or not). My personal opinion is that the FDA will respond (soon - either before Dec 31st or close to that date, as required by law), but will likely have questions/request clarifications. I'm confident that XXII's MRTP application will be approved - which indeed will make it the first and only company to have an MRTProduct on the market, and which I think almost everyone agrees will be a game-changer for XXII (and us shareholders); however "approval (or not) by December 31st" is not accurate.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News